AngioDynamics, Inc.
ANGO Healthcare Medical Instruments & Supplies
AngioDynamics, Inc.’s revenue for fiscal 2026 (year ended May 2026) was $320.2 million, up 9.46% from fiscal 2025. In the quarter to August 2026, revenue grew 6.87%, EPS grew 35.0% and free cash flow grew 5.62%, each against the same quarter a year earlier.
Follow ANGO
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Older periods | Nov '25 | Feb '26 | May '26 | Aug '26 | |
|---|---|---|---|---|---|
Cash and Short Term Investments |
+8 more quarters Free account |
41.64 | 37.81 | 53.86 | 33.97 |
Receivables |
44.43 | 45.55 | 48.33 | 44.91 | |
Inventory |
65.57 | 58.58 | 52.44 | 54.95 | |
Total current assets |
161.35 | 155.55 | 163.39 | 143.00 | |
Property, Plant, Equpment (Net) |
30.53 | 29.14 | 27.10 | 27.73 | |
Goodwill and Intangible Assets (Total) |
66.73 | 65.49 | 67.21 | 61.89 | |
Long-term assets (Other) |
11.07 | 10.50 | 9.46 | 9.31 | |
Total non-current assets |
108.33 | 105.13 | 103.77 | 98.93 | |
Total Assets |
269.68 | 260.68 | 267.16 | 241.93 | |
Accounts Payable |
35.39 | 29.11 | 31.51 | 26.58 | |
Accrued Expenses |
29.85 | 32.30 | 38.91 | 28.81 | |
Other current liabilities |
6.72 | 4.66 | 4.30 | 4.30 | |
Total current liabilities |
71.96 | 66.07 | 74.72 | 59.69 | |
Long Term Tax Liability (Deferred) |
4.33 | 4.55 | 5.32 | 4.68 | |
Non-current Liabilities (Other) |
17.05 | 16.70 | 16.31 | 13.60 | |
Total non-current liabilities |
21.39 | 21.26 | 21.62 | 18.28 | |
Total liabilities |
93.35 | 87.32 | 96.34 | 77.97 | |
Additional Paid In Capital |
628.78 | 632.18 | 636.08 | 639.31 | |
Common Stock (Net) |
0.39 | 0.39 | 0.39 | 0.39 | |
Retained Earnings |
(446.45) | (454.53) | (465.94) | (473.04) | |
Treasury Stock |
7.38 | 7.38 | 7.38 | 7.38 | |
Common Equity (Total) |
176.33 | 173.36 | 170.83 | 163.96 | |
Shareholders Equity (Total) |
176.33 | 173.36 | 170.83 | 163.96 | |
Shareholders Equity and Liabilities (Total) |
269.68 | 260.68 | 267.16 | 241.93 | |
Shares (Common) |
41.57 | 41.68 | 41.70 | 42.42 | |
Shareholders Equity (Tangible) |
109.60 | 107.87 | 103.62 | 102.07 | |
Net Debt |
(41.64) | (37.81) | (53.86) | (33.97) |